On April 22, the 2026 JD Pharmacy Partner Conference was held in Beijing. Marking the tenth anniversary of JD Pharmacy, JD Health (06618) showcased its comprehensive AI advancements for pharmaceutical services for the first time, built upon its self-developed "Jingyi Qianxun" large language model. The initiative ranges from an AI physician agent cluster integrated across the JD APP, JD Health APP, and WeChat ecosystems, to the launch of the industry-leading "Drug Intelligence Model" and a suite of AI-powered medication services. JD Health is positioning "Medical-Grade AI" as its core engine to evolve pharmaceutical and health services from mere accessibility towards a new decade characterized by full-cycle, personalized, and deterministic care.
The integration of the AI physician cluster across the JD APP and WeChat ecosystems embeds professional healthcare guardianship into daily life. This upgrade enables seamless multi-platform connectivity, ensuring a professional team comprising doctors, pharmacists, and nutritionists is perpetually online and integrated into users' everyday routines. A key breakthrough is the transformation of the AI physician from a passive Q&A tool into a full-cycle health manager endowed with long-term memory and proactive management capabilities. It memorizes each family member's health records and medication habits, actively identifying health risks through intelligent alerts, scheduled check-ins, and personalized interventions. For instance, the system can predict when a user's medication supply is running low, automatically sending reminders and facilitating a seamless transition to consultation and prescription refill services. Upon uploading medical reports, the AI coordinates with professional teams to provide closed-loop solutions.
Crucially, the AI physician deeply integrates a closed-loop service encompassing "consultation, testing, diagnosis, and medication." After a user raises a query, the system not only offers professional advice but also directly connects them to JD Internet Hospital for online consultations, JD Daojia for rapid testing, JD Nurse home visits, AI-assisted diagnostics, and JD Pharmacy for medication fulfillment. This creates a comprehensive service loop enabling "consultation, diagnosis, testing, medication, and management," allowing patients to access a full spectrum of medical services—from online doctor visits and at-home tests to delivered medications and nursing care—without leaving their homes. This fundamentally distinguishes it from common conversational AI health products; JD Health is building a "medical-grade AI" that delivers on its promises, not just a conversational life assistant.
Technologically, the AI physician is powered by the "Jingyi Qianxun" large model, which topped two leaderboards on the authoritative medical AI evaluation platform MedBench. It possesses evidence-based reasoning capabilities that "think like a doctor," achieving a 99.6% accuracy rate in intercepting prescription risks and covering 26 types of high-risk scenarios, ensuring clinical-grade rigor for medication safety. To date, the AI physician services based on "Jingyi Qianxun" have covered hundreds of millions of families, with user satisfaction exceeding 98%. This upgrade represents JD Health's strategic shift from single-point consultations to comprehensive, full-scenario family health management.
Simultaneously, JD Health systematically introduced its "Drug Intelligence Model" for the entire pharmaceutical industry chain. Built upon the "Jingyi Qianxun" model and trained on 40 million authoritative knowledge sources, 2 million medical entities, and billions of user behaviors, the model leverages JD's robust pharmaceutical supply chain to drive the implementation of practical AI applications. The AI Pharmacist, based on this model, offers 7x24 full-process services: translating users' vague descriptions of discomfort into clear medication plans before purchase, providing personalized medication guidance during purchase, and proactively reminding users of refills and follow-up consultations post-purchase, thereby helping chronic disease patients adhere to standardized treatment cycles. Handling millions of prescriptions daily, the AI Pharmacist maximizes medication safety with its 99.6% risk interception accuracy.
Addressing the global challenge of "medication adherence" faced by over 500 million chronic disease patients in China, JD Health officially launched "Yao Xiao Zhi." This product features long-term memory and a reflection model, creating tailored management plans for patients covering medication guidance, scheduling, and reminders, evolving into a lifelong companion that understands users better over time and solves the pain points of "not knowing how to use, using incorrectly, or struggling to persist."
Concurrently, the newly launched "Global Drug Search Platform" utilizes JD Health's extensive database of over 170,000 medical knowledge graphs and its powerful supply chain network to achieve a rapid closed-loop process from identifying user needs and sourcing drugs to introduction and fulfillment. Instead of receiving a generic "no results found" message, patients searching for hard-to-find medications can now transition from "finding" to "purchasing" the drugs.
For pharmaceutical partners, JD Health is positioning AI as a "force multiplier." It offers customized intelligent agents based on the "Drug Intelligence Model," integrating partners' proprietary knowledge bases to create "dedicated knowledge brains." Furthermore, it has introduced a compliant, efficient, precise, and fully traceable digital academic promotion platform. This platform uses highly realistic AI digital human experts to deliver multimodal academic explanations and interactions, accurately identifying target audiences and intelligently pushing personalized content, thereby aiding pharmaceutical companies in transitioning from "experience-driven" to "data-driven" operations.
From the AI physician agent cluster serving hundreds of millions of families to the "Drug Intelligence Model" empowering thousands of pharmaceutical companies, JD Health is leveraging medical-grade AI to pragmatically address the "determinism" required in healthcare and the "personalization" desired by users, ushering in the next decade of pharmaceutical health services and making professional, intelligent healthcare accessible to every household.
Comments